SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

NEGRINI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.152
AS - Asia 16.246
EU - Europa 11.792
SA - Sud America 2.426
AF - Africa 364
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 14
Totale 62.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.540
SG - Singapore 6.310
CN - Cina 4.024
FI - Finlandia 2.724
DE - Germania 1.949
IT - Italia 1.858
BR - Brasile 1.829
VN - Vietnam 1.799
UA - Ucraina 1.386
HK - Hong Kong 1.327
GB - Regno Unito 994
TR - Turchia 979
PL - Polonia 623
FR - Francia 524
SE - Svezia 491
RU - Federazione Russa 403
JP - Giappone 356
IN - India 352
CA - Canada 280
MX - Messico 262
ID - Indonesia 232
AR - Argentina 230
BD - Bangladesh 199
NL - Olanda 178
ZA - Sudafrica 126
BE - Belgio 114
ES - Italia 112
IQ - Iraq 106
PK - Pakistan 89
AT - Austria 86
EC - Ecuador 84
CZ - Repubblica Ceca 74
CO - Colombia 68
VE - Venezuela 63
LT - Lituania 59
SA - Arabia Saudita 57
UZ - Uzbekistan 55
CL - Cile 48
RO - Romania 45
PH - Filippine 43
MA - Marocco 40
TN - Tunisia 39
MY - Malesia 38
AU - Australia 35
AE - Emirati Arabi Uniti 33
EG - Egitto 31
IR - Iran 31
JO - Giordania 30
KE - Kenya 30
PY - Paraguay 29
IE - Irlanda 27
BO - Bolivia 25
UY - Uruguay 25
CH - Svizzera 23
DZ - Algeria 22
IL - Israele 20
KR - Corea 19
OM - Oman 19
PE - Perù 19
LB - Libano 17
NP - Nepal 17
ET - Etiopia 15
DO - Repubblica Dominicana 14
GR - Grecia 14
TH - Thailandia 14
AL - Albania 13
KZ - Kazakistan 11
LV - Lettonia 11
NG - Nigeria 11
RS - Serbia 11
AZ - Azerbaigian 10
HR - Croazia 10
CR - Costa Rica 9
DK - Danimarca 9
HN - Honduras 9
JM - Giamaica 9
SN - Senegal 9
BG - Bulgaria 8
EU - Europa 8
PA - Panama 8
PT - Portogallo 8
CI - Costa d'Avorio 7
HU - Ungheria 7
TW - Taiwan 7
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
LY - Libia 5
MD - Moldavia 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
KH - Cambogia 4
MU - Mauritius 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
XK - ???statistics.table.value.countryCode.XK??? 4
BF - Burkina Faso 3
Totale 61.951
Salva come PNG Salva come JPEG
Città #
Singapore 3.931
Ashburn 3.582
Fairfield 2.944
Woodbridge 2.756
Helsinki 2.245
Houston 1.905
San Jose 1.703
Chandler 1.547
Jacksonville 1.506
Hong Kong 1.288
Beijing 1.273
Santa Clara 1.238
Ann Arbor 1.189
Seattle 1.104
Wilmington 1.030
Cambridge 904
Munich 753
Warsaw 607
Ho Chi Minh City 585
New York 582
Izmir 563
Los Angeles 522
Nanjing 467
Dallas 462
Hanoi 397
Ferrara 391
Princeton 346
Tokyo 339
Lauterbourg 297
San Diego 275
Milan 256
Boardman 250
Shanghai 220
São Paulo 193
Mexico City 162
Orem 161
Council Bluffs 160
Jakarta 159
Turku 158
London 148
Nanchang 140
Shenyang 131
Tianjin 121
Hefei 113
Montreal 111
Bremen 110
Buffalo 107
Brussels 106
Dearborn 103
Brooklyn 101
Chicago 100
Denver 98
Addison 90
Falls Church 87
Chennai 86
Atlanta 85
Johannesburg 84
The Dalles 84
Changsha 83
Dong Ket 81
Amsterdam 80
Da Nang 79
Stockholm 74
Poplar 73
Frankfurt am Main 71
Hebei 71
Haiphong 70
Moscow 69
Toronto 69
Jiaxing 68
Rome 68
Bologna 66
Jinan 65
Phoenix 65
Rio de Janeiro 64
Guangzhou 61
Manchester 61
Mountain View 61
Boston 57
Falkenstein 57
Nuremberg 56
San Mateo 56
Kunming 55
San Francisco 54
Washington 50
Mumbai 49
Ankara 48
Redwood City 48
Brno 46
Norwalk 46
Tashkent 46
Vienna 45
Zhengzhou 44
Ningbo 43
Columbus 39
Baghdad 38
Hangzhou 37
Auburn Hills 34
Augusta 33
Hải Dương 33
Totale 42.868
Salva come PNG Salva come JPEG
Nome #
An in vitro method for the diagnosis of neoplastic diseases by methylation analysis of the CDH4 gene, oligonucleotides and kits useful in such method 2.032
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 662
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 402
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 368
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 351
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 333
Absolute quantification of cell-free microRNAs in cancer patients 328
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 317
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 312
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 310
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 305
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 297
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 297
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 296
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 294
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 293
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 290
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 284
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 281
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 279
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 272
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 268
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 264
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 263
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 260
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 259
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 258
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 257
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 257
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 254
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 251
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 247
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 247
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 247
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 247
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 246
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 245
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 243
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 242
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 242
BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors 237
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 237
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 236
Circulating non-coding RNA as biomarkers in colorectal cancer 236
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 235
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 235
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 233
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 232
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 230
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 229
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 229
MicroRNA e cancro 229
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 226
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 226
MicroRNA involvement in hepatocellular carcinoma 224
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 224
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 223
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 222
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 222
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 220
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 218
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 218
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 218
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 217
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 217
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 217
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 216
Reprogramming of miRNA networks in cancer and leukemia 215
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 215
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 214
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 214
A microRNA signature of hypoxia 214
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 214
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 214
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 214
Animal Models of Hepatocellular Carcinoma Prevention 213
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 212
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 212
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 210
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 209
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 208
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 207
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 207
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: POLYOMAVIRUSES AND HUMAN DISEASES 205
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 204
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 204
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 204
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 203
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 203
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 202
Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor 200
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 200
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 199
Non-coding RNAs in the reprogramming of glucose metabolism in cancer 197
Espressione dei MicroRNA nei carcinomi mammari 196
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 195
Aberrant FHIT transcripts in Merkel cell carcinoma 194
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 194
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 194
Totale 26.298
Salva come PNG Salva come JPEG
Categoria #
all - tutte 255.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.292
Totale 265.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.755 0 0 0 0 0 0 0 0 0 692 701 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20258.797 188 179 650 350 1.005 859 481 499 1.606 794 1.223 963
2025/202623.252 2.253 909 1.871 2.968 3.333 1.545 2.989 1.292 4.185 1.907 0 0
Totale 62.558